Congenital muscle fiber-type disproportion

Harvey B Sarnat MS MD FRCPC

Developmental Malformations

Updated 04.28.2024
Released 03.23.1994
Expires For CME 04.28.2027

Congenital muscle fiber-type disproportion

Author: Harvey B Sarnat MS MD FRCPC

See Contributor Disclosures

Congenital muscle fiber-type disproportion

In This Article

Quick Link

Introduction

Overview

Congenital muscle fiber-type disproportion is a condition that can be defined only in the muscle biopsy by two obligatory criteria of “disproportion”: (1) a massive type I myofiber predominance is 80% or more, and (2) myofibers of type I are uniformly smaller than normal for age by two standard deviations or more but are not necessarily angular or rounded as in myofiber atrophy. Internal sarcolemmal nuclei are an inconstant additional feature in a minority of cases, but myofiber necrosis, inflammation, and fibrosis are not typical features. This condition may be isolated as a nonprogressive congenital myopathy inherited as an autosomal dominant or recessive trait; may be associated with other congenital myopathies, such as nemaline rod myopathy, minicore myopathy, and infantile myotonic dystrophy; and may present with a variety of genetic metabolic diseases, including Krabbe leukodystrophy in early stages and insulin-resistant diabetes mellitus. It is also associated with congenital malformations of the brain, particularly cerebellar hypoplasia. Clinically, patients often have dysmorphic facies with facial wasting similar to that of nemaline myopathy or myotonic dystrophy. Serum creatine kinase is normal, and EMG is nondiagnostic. Congenital muscle fiber-type disproportion is best regarded as a syndrome and not a specific disease, except for isolated familial cases.

Key points

	• Congenital muscle fiber-type disproportion is a syndrome, not a disease; most cases are of diverse genetic origins, but it also can occur secondary to some brain malformations that generate abnormal signalling to spinal motor neurons.
	• Pathological major criteria are: (1) uniform smallness of type I myofibers and (2) type I myofiber predominance. Pathological minor criteria are: (3) small myofibers remain polygonal, not angular, in transverse contour; (4) myofiber necrosis and degeneration is not a feature; (5) centronuclear fibers occur in a minority of cases.
	• Congenital muscle fiber-type disproportion associated with several congenital myopathies (neonatal myotonic dystrophy; nemaline myopathy) may occur as an isolated congenital myopathy, is associated with several systemic inborn metabolic diseases (multiple sulfatase deficiency; some mitochondrial cytopathies; Krabbe disease), and may be secondary to suprasegmental abnormal influences on the motor unit in midfetal life, particularly cerebellar hypoplasia and other posterior fossa malformations; this is not due to denervation or reinnervation of muscle (spinal muscular atrophy, congenital or genetic polyneuropathies).
	• Many diverse genes are now known to be associated, in addition to those that cause nemaline myopathy, but phenotype/genotype correlation often is poor because of the same mutation with different expressions within even a family or an individual at different ages.
	• Serum CK is normal; EMG is nondiagnostic; NCV is normal.
	• Clinical phenotype is variable, depending on the associated disease (facial weakness and wasting in myotonic dystrophy and nemaline myopathy). Arthrogryposis is rare, but isolated contractures of proximal and distal joints may occur, and scoliosis is a frequent complication; cardiomyopathy is rare and is associated with specific genetic mutations, such as ACTA1.

Historical note and terminology

The unique ratio of histochemical fiber types and sizes in the muscle biopsy of infants and children was described by Brooke and Engel (17), Farkas-Bargeton and colleagues (45), Karpati and colleagues (66), and Caille and colleagues (20) but was first recognized as a distinct entity and called "congenital fiber-type disproportion" by Brooke (15). He initially defined a difference in fiber size, type I smaller than II by 12% or more, but in later publications, he reconsidered and changed his criteria to 25% or more because the earlier difference was too little and, in most cases, even 25% was a conservative ratio. The 25% difference in fiber size is now accepted as the standard (32). By definition, it is a muscle biopsy diagnosis of selective uniform smallness of type I fibers relative to those of type II by 25% or more and also type I myofiber predominance of 80% or more. “Partial congenital muscle fiber-type disproportion” may be defined by uniform type I myofiber smallness but without the numerical predominance of classical congenital muscle fiber-type disproportion. This form is more usual in systemic metabolic diseases. An additional feature in some patients with congenital muscle fiber-type disproportion is the presence of large numbers of centronuclear fibers that are not regenerative fibers (134; 143; 21). In rare cases, type II fibers, rather than undergoing the usual compensatory hypertrophy, may become atrophic and angular (111).

Because the genetics are uncertain in most cases, despite the discovery of many new genetic mutations (see below), and because congenital muscle fiber-type disproportion is found in association with many other myopathies and diseases, Dubowitz characterized this unique histopathological pattern as “a pathology in search of a disease (42).

CMFTD in a 6-month-old boy (vastus lateralis muscle biopsy)

This muscle biopsy is from a 6-month-old boy with congenital muscle fiber-type disproportion. Formalin-fixed, paraffin-embedded, transverse section stained with hematoxylin-eosin shows normal fascicular architecture of the muscle,...
Generalized hypotonia, thin muscle mass, and mild axial weakness (1)

Muscle biopsy in a 6-month-old boy. Frozen section, modified Gomori trichrome stain reveals no nemaline rods, ragged-red fibers, or abnormal inclusions; small myofibers maintain a normal polygonal contour and are not angular. Magn...
Generalized hypotonia, thin muscle mass, and mild axial weakness (2)

Muscle biopsy in a 6-month-old boy. Myofibrillar ATPase preincubated at pH 10.2 shows that the entire population of large fibers are type II and are uniformly distributed within the fascicles and not grouped. Magnification x 250. ...
Generalized hypotonia, thin muscle mass, and mild axial weakness (3)

Muscle biopsy in a 6-month-old boy. Myofibrillar ATPase preincubated at pH 4.7 shows the entire population of small fibers to be type I; there is an 80% predominance of type I fibers. Magnification x 100. (Contributed by Dr. Harve...
Generalized hypotonia, thin muscle mass, and mild axial weakness (4)

Muscle biopsy in a 6-month-old boy. Myofibrillar ATPase preincubated at pH 4.4 is similar to pH 4.7, showing the entire population of small fibers to be type I. Magnification x 250. (Contributed by Dr. Harvey Sarnat.)
Generalized hypotonia, thin muscle mass, and mild axial weakness (5)

Muscle biopsy in a 6-month-old boy. NADH-TR reveals normal oxidative "mitochondrial" enzymatic activity and confirms the type I identity of the small fibers. Magnification x 250. (Contributed by Dr. Harvey Sarnat.)
Generalized hypotonia, thin muscle mass, and mild axial weakness (6)

Muscle biopsy in a 6-month-old boy. Periodic acid-Schiff stain reveals glycogen more abundant, but not excessive, in type II fibers as expected. Magnification x 250. (Contributed by Dr. Harvey Sarnat.)
Generalized hypotonia, thin muscle mass, and mild axial weakness (7)

Muscle biopsy in a 6-month-old boy. Oil red O stain reveals punctate neutral lipid to be more abundant, though not excessive, in type II fibers, a reversal of the normal expected pattern often found in congenital muscle fiber-type...

The ultrastructure of muscle in congenital muscle fiber-type disproportion shows only subtle changes without myofiber necrosis. The Z-band tends to be less regular than normal, and excessive Z-band streaming sometimes is seen (22). This finding is of interest because congenital muscle fiber-type disproportion is a constant feature in nemaline rod myopathy (see below), and nemaline rods are derived from Z-band material. Other findings by electron microscopy are abnormal exchanges of bundles of myofilaments between adjacent myofibrils and occasional peripheral sarcoplasmic masses containing bundles of disoriented myofilaments (22). In cases with demonstrated genetic mutations in the molecular structure of contractile proteins (see below), these specific myofilaments of actin or myosin are ultrastructurally altered and may predict the genetic defect.

Both the clinical features and the muscle biopsy findings were subsequently confirmed by many other authors. The diverse etiologies of the disorder as a syndrome rather than a disease and its association in some cases with specific metabolic diseases were first recognized by Martin and colleagues (87). The association with cerebellar hypoplasia was documented by Sarnat (125). A review of the known genetic mutations was provided by DeChene and colleagues (39).

Clinical manifestations

Presentation and course

The diagnosis of congenital muscle fiber-type disproportion must be established by muscle biopsy, and one may distinguish the "pure congenital myopathy" from the congenital muscle fiber-type disproportion syndrome associated with a large number of other hereditary and nonhereditary conditions. Even the pure myopathic form might be denied as a "congenital myopathy" if genetic transmission is used as an obligatory criterion. Only rarely is Mendelian transmission demonstrated (70; 68). In some families, nevertheless, autosomal dominant inheritance is clearly demonstrated (148); in other families an autosomal recessive trait is suspected from similar involvement of siblings of both genders.

The clinical expression varies with the diverse etiologies of this syndrome in those cases with identified metabolic or neurologic diseases. Among patients in whom congenital muscle fiber-type disproportion occurs as an apparent isolated "congenital myopathy,” the clinical presentation is variable. Manifestations may be severe at birth and in infancy or may be mild. The severe clinical pattern often, but not always, has an additional muscle biopsy finding of centronuclear fibers (109; 79; 169). If congenital muscle fiber-type disproportion is associated with nemaline rods, as it nearly always is in nemaline myopathy, the clinical pattern also is usually one of severe weakness. Even as an isolated congenital myopathy, weakness may be generalized and severe, but static, though most cases have only mild weakness and a benign clinical course (32). In a study of 67 cases of idiopathic congenital muscle fiber-type disproportion, 25% had contractures, scoliosis, or other deformities, and failure to thrive was common in infancy. The diagnosis of clubfoot with polyhydramnios can be made prenatally at times by ultrasound (12). About 25% had a severe clinical course and 10% died in childhood, usually of respiratory insufficiency or pneumonia (32). Ophthalmoplegia, facial weakness, and other bulbar motor deficits were associated with a poorer prognosis.

Most patients present at birth with hypotonia, proximal generalized weakness, and small muscle mass. Intelligence is normal and there are no other indications of cerebral dysfunction (32; 60). In the severe infantile form of the syndrome, the weakness at birth involves axial and appendicular muscles, facial and other bulbar-innervated muscles, and may require ventilatory support and gavage feeding. In some cases, gastrostomy may be recommended because of feeding difficulties with dysphagia, aspiration, and frequent pulmonary infections secondary to aspiration. The facial weakness is prominent, but the typical inverted V-shaped upper lip is usually seen when congenital muscle fiber-type disproportion is due to myotonic dystrophy, and the everted lips characteristic of facioscapulohumeral muscular dystrophy do not occur. Ptosis and variable external ophthalmoplegia are often present, and pharyngeal muscles are weak (24; 106; 79; 155). The tongue is thin but no fasciculations are seen. The muscle mass of the trunk and extremities is thin. Tendon reflexes are hypoactive or absent. Congenital contractures, scoliosis, and deformities of the feet or clubfoot may be present (78; 27; 80; 32). Severe arthrogryposis is exceptional but is reported (158; 49). In reading case reports, one must carefully evaluate whether the muscle biopsy fulfills the histochemical criteria of congenital muscle fiber-type disproportion because titles of some articles use this term rather indiscriminately.

In early infancy, congenital muscle fiber-type disproportion may have a clinical presentation suggestive of congenital myasthenia gravis, particularly if associated with the tropomyosin 3 (TPM3) gene (94). The discovery of autosomal recessive mutations in the RYR1 gene product associated with defective motor end plates of ryanodine receptors in some cases of congenital muscle fiber-type disproportion further explains this similar clinical picture (33; 28).

Cardiomyopathy is rare in congenital muscle fiber-type disproportion, but exceptional cases with dilated cardiomyopathy and intractable congestive heart failure requiring cardiac transplantation in early adolescence are described (08). Cardiomyopathy also was a feature in three Dutch families in whom myofibrillar lysis was an additional feature (09). In some cases of congenital muscle fiber-type disproportion with severe dilated cardiomyopathy, specific unique genetic mutations are identified (153). Cardiomyopathy also may be less severe, but sufficient to cause mild congestive heart failure with pedal edema (60). Some cases with cardiomyopathy are so mild in childhood that they are not recognized until adult life (47).

Respiratory weakness, ranging from mild to severe, occurs in 30% of children with congenital muscle fiber-type disproportion (39).

Gastrointestinal tract dysmotility with poor peristalsis and fecal impaction in the bowel is not a characteristic feature, but it is found in occasional cases (72), similar to the smooth muscle dysfunction in infantile myotonic dystrophy. Mild to severe feeding difficulties occur in nearly 30% of affected individuals (39).

Some infants die in the neonatal period or early infancy. Those who survive stabilize clinically and may eventually breathe adequately without ventilator support and are able to feed slowly, but continue to have severe generalized weakness, poor head control, and delayed gross motor development. Others remain ventilator-dependent for years (52; 155). Signs of central nervous system disease such as mental retardation, seizures, or corticospinal tract signs do not appear unless hypoxia is superimposed as a secondary insult. In later childhood, they require an electric wheelchair because they never walk and their arms remain too weak to use a manual wheelchair, but they may feed themselves with specially designed aids and learn to use a computer keyboard for schoolwork.

The muscle biopsy not only confirms the diagnosis of congenital muscle fiber-type disproportion, but also may have some predictive value of the severe or mild clinical expression of the myopathy. However, the muscle biopsy finding may change in time so that most patients continue to show smallness of type I fibers, but the type I predominance becomes even greater after several years (149; Sarnat unpublished observations). In other patients, by contrast, the type I fiber hypoplasia may resolve so that infants with typical congenital muscle fiber-type disproportion no longer have small type I fibers by adolescence, and the type I fibers may indeed actually become larger than the type II fibers; it is postulated that after the type II fibers have undergone as much compensatory hypertrophy as they can, the type I fibers then grow in size and become hypertrophic (10). Some of these patients also show improvement in their strength and stamina (10). Brooke found a relative absence of subtype IIb fibers (< 5%) (16). In some cases, simple congenital muscle fiber-type disproportion in early childhood evolves to become a centronuclear myopathy as well as persistence of congenital muscle fiber-type disproportion by adult life (21).

If the severe form is accompanied by many centronuclear fibers in the muscle biopsy, there may be progressive changes in serial muscle biopsies over time, with a decrease in type II myosin light chains 2 and 3 that suggest type I fiber deficiency in terms of total volume of type I myofibrils. Such children are severely disabled, never walk, and may require chronic ventilatory support (37). Even in mild, clinically nonprogressive cases, there may be a histochemical continuation of the process of conversion of type II fibers to type I so that the ratio becomes even more extreme during later childhood and adolescence (144).

Vastus lateralis muscle biopsy of a 9-year-old boy (1)

Paraffin transverse sections stained with hematoxylin-eosin show normal muscle architecture, no connective tissue proliferation, necrosis, or regeneration, and two populations of fibers by size. Magnification of A is x100, and ...
Vastus lateralis muscle biopsy of a 9-year-old boy (2)

(A and B) Two regions of the biopsy stained with modified Gomori trichrome to show absence of nemaline rods from both size populations of myofibers, central nuclei, or other alterations. Magnification x 250. (Contributed by Dr. Ha...
Vastus lateralis muscle biopsy of a 9-year-old boy (3)

(A to C) NADH-TR of several different fascicles shows that all small fibers are type I and all large fibers are type II, but some fascicles are composed nearly entirely of small type I fibers. ATPase stains (not shown) confirmed a...

In the mild clinical form of congenital muscle fiber-type disproportion, the body habitus and phenotypic features are similar to those of the severe form: a generally thin muscle mass at birth, generalized hypotonia often of severe degree, hypoactive tendon reflexes, poor head control in infancy, and mild generalized weakness (24; 27; 109; 25; 147; 146). Though gross motor development may be delayed, mildly affected children learn to walk, often with a Trendelenburg gait, and have no difficulty in using their arms for ordinary activities. Inability to lift their arms above their heads is explained by prominent scapular winging, indicating poor fixation of the scapula for rotation. As with the severe form, marked dolichocephaly and facial weakness are present, and the facies are accentuated by the deficient mass of the temporalis muscles in particular. The palate is narrow and high-arched. Severe skeletal open bite, incompetent lips, maxillary arch, and EMG evidence of weakness of masticatory muscles are present. These congenital craniofacial features are similar to the neonatal form of myotonic dystrophy (07). Ptosis and weakness of extraocular muscles may be present but are less common than in the severe form. In the neonatal period, there are no difficulties with respiration or feeding. Intellectual development is normal, and no signs of central nervous system disease are evident.

The myopathy is nonprogressive and may even improve clinically as the child grows (36; 27; 59; 02). In some cases, myopathy is not even detected until midchildhood, when it presents as a slowly progressive or nonprogressive mild proximal weakness (43). Even a 20-year-old adult man with a "marfanoid habitus" was found to have congenital muscle fiber-type disproportion on muscle biopsy (56). In some cases, episodic progressive weakness is reported, but these cases are usually associated with additional myopathic findings such as centronuclear fibers or cytoplasmic bodies in myofibers, or an excessive number of immature myotubes (146).

Congenital muscle fiber-type disproportion as an isolated myopathy, without other associated conditions, thus, is not fundamentally a progressive disease and is not a necrotizing myopathy or a muscular dystrophy. Patients who exhibit centronuclear myopathy in addition to congenital muscle fiber-type disproportion generally experience greater weakness, including dysphagia and respiratory muscle weakness, than do patients with only rare centronuclear muscle fibers. Some patients appear to show increasing numbers of centronuclear fibers over years with serial muscle biopsies and may exhibit some additional clinical weakness as well, as already noted (02; 37). In addition, most children show a progressive conversion of more type II fibers to type I, so biopsies in older children may show almost exclusively type I fibers and only rare scattered type II fibers. Progressive clinical signs do not necessarily accompany this change in the ratio of fiber types, however, and clinical course and histochemical change over time should be considered separately and not equated. The clinical variability and apparent clinical progression might be due in part to growth spurts. Whereas histochemical fiber types are traditionally determined by myosin (calcium-mediated) ATPase stains preincubated at acid and alkaline pH ranges, heavy-chain myosin immunocytochemical antibodies against type II fibers in paraffin sections demonstrate the same pattern of fiber type differentiation in congenital muscle fiber-type disproportion as in normal muscle biopsies (116).

Complications include dislocations of the shoulder or other joints because of severe hypotonia, fractures of long bones because of thin and weak muscle cylinder, respiratory infections, and, in the severe form, aspiration. Scoliosis and other spinal deformities occur in 25% of patients (39). Scoliosis is a serious complication in patients confined to a wheelchair, but kyphoscoliosis sometimes develops in ambulatory patients as well (78). Contractures may also occur in the hips, knees, ankles, elbows, and fingers in approximately 25% of cases (39).

Patients requiring chronic ventilator support for years may develop cardiac complications, but cardiac and smooth muscles are not primarily involved. Congenital anomalies of other organ systems do not usually occur, but one case is reported with coarctation of the aorta (99). Cardiomyopathy has already been discussed. Myotonia occurs only in those cases associated with myotonic muscular dystrophy and rarely before 5 years of age.

Cases associated with cerebellar hypoplasia are difficult to distinguish in early infancy because of the shared clinical findings of delayed gross motor development and generalized hypotonia, but infants follow the mild rather than the severe form of congenital muscle fiber-type disproportion. Ataxia and intention tremor may become evident as the child matures, and nystagmus is uncommon (132). Facial weakness and dolichocephaly are often absent in congenital muscle fiber-type disproportion associated with cerebellar hypoplasia. In some cases, intellectual deficits and seizures may provide additional distinguishing features of CNS involvement, and delayed corticospinal tract maturation may result in hyperreflexia.

Congenital muscle fiber-type disproportion is not regularly associated with systemic malformations of other organ systems except for the central nervous system dysgeneses already mentioned. A few cases are reported in patients with congenital heart disease or mitral valve prolapse (38), and rare patients with chromosomal disease and congenital muscle fiber-type disproportion have anomalies of other organs.

Prognosis and complications

Severely involved infants with congenital muscle fiber-type disproportion are at risk for early respiratory failure or aspiration leading to death. Congenital muscle fiber-type disproportion is generally not a progressive disease, however, and patients stabilize with persistent hypotonia and weakness that may even improve mildly with time and growth (36; 27; 59). The muscle biopsy generally remains unchanged, but in some cases the disproportion in size and types of myofibers may diminish or even resolve, though fiber-type predominance usually persists (113; 59; 89; 10). In some cases, the quantitative disproportion may even intensify with time and become more pronounced after 6 months of age on repeat muscle biopsy (59), or the size ratio remains unchanged, but the type I predominance becomes more pronounced. In this regard, a nonprogressive "congenital myopathy" is described that is characterized by uniform type I myofibers and lack of differentiation of type II fibers (41; 103; 156); whether such children had congenital muscle fiber-type disproportion earlier in life with this single fiber type as the end result is speculative. Some children with nemaline rod myopathy show just such a pattern of evolution in their repeat muscle biopsy years later (124). The clinical characteristics of congenital muscle fiber-type disproportion are similar regardless of the degree of type I predominance (96). Some cases of congenital muscle fiber-type disproportion are so mild that they are not recognized as a myopathy until adult life (108).

If congenital muscle fiber-type disproportion is associated with another neuromuscular, neurologic, or metabolic disease, the prognosis is that of the primary disease. In congenital muscle fiber-type disproportion secondary to cerebellar hypoplasia, the muscle findings do not appear progressive either clinically or histologically (125; 126).

Cardiac involvement in congenital muscle fiber-type disproportion is rare, except if secondary to a systemic metabolic disease with cardiomyopathy, such as Pompe disease (glycogenosis II). Nevertheless, some cases of isolated congenital muscle fiber-type disproportion are described with cardiac involvement in later childhood or adolescence (93).

Biological basis

Etiology and pathogenesis

Both genetic and epigenetic causes of this muscle biopsy phenotype are well documented (110; 26; 108). Congenital muscle fiber-type disproportion can be divided into several etiologic categories: (1) an isolated “congenital myopathy,” probably an autosomal recessive trait for which the genetic mutation is not yet known in all cases but is well documented in others (Table 1); (2) associated with other better defined myopathies including nemaline rod myopathy, the severe congenital form of myotonic dystrophy, rigid spine myopathy, and some centronuclear myopathies; (3) association with suprasegmental developmental malformations of the CNS, particularly cerebellar hypoplasia and Moebius syndrome; (4) association, in some cases, with systemic metabolic diseases, including Krabbe disease (globoid cell leukodystrophy), multiple sulfatase deficiency, mitochondrial cytopathies, Lowe disease, and glycogenoses II, III, and IX; and (5) association with acquired perinatal disorders, such as fetal alcohol syndrome.

Multiple causative genes are implicated in congenital muscle fiber-type disproportion (102). Genotype/phenotype correlations in congenital myopathies in general are complicated by several factors: (1) congenital myopathies can be caused by mutations in more than one gene; (2) mutations in the same gene can cause different muscular pathologies; (3) the same genetic mutation may lead to different pathological features in members of the same family or even in the same individual at different ages (167).

In most cases, congenital muscle fiber-type disproportion is a "congenital myopathy" of unknown etiology that occurs sporadically without an identified genetic trait. Rare families with congenital muscle fiber-type disproportion are described (09). Fiber-type disproportion is not confined to human myopathies but is also described in a juvenile canine (114).

Vastus lateralis muscle biopsy of a 9-year-old boy (1)

Paraffin transverse sections stained with hematoxylin-eosin show normal muscle architecture, no connective tissue proliferation, necrosis, or regeneration, and two populations of fibers by size. Magnification of A is x100, and ...
Vastus lateralis muscle biopsy of a 9-year-old boy (2)

(A and B) Two regions of the biopsy stained with modified Gomori trichrome to show absence of nemaline rods from both size populations of myofibers, central nuclei, or other alterations. Magnification x 250. (Contributed by Dr. Ha...
Vastus lateralis muscle biopsy of a 9-year-old boy (3)

(A to C) NADH-TR of several different fascicles shows that all small fibers are type I and all large fibers are type II, but some fascicles are composed nearly entirely of small type I fibers. ATPase stains (not shown) confirmed a...

Some cases are associated with other neuromuscular or metabolic diseases (Table 1), which include (1) all cases of nemaline rod myopathy, except for those in which no type II myofibers are differentiated (124; 145); (2) the infantile form of myotonic dystrophy (135; 04; 154); (3) Krabbe globoid cell leukodystrophy (87; 40; 84); (4) multiple sulfatase deficiencies (152); (5) a minority of cases of glycogenosis II (infantile acid maltase deficiency or Pompe disease) (87), a minority of cases of glycogenosis III (debrancher enzyme deficiency or Cori-Forbes disease) (87), and rare cases of glycogenesis IX (phosphorylase kinase B deficiency) or of muscle phosphoglyceromutase deficiency (Sarnat unpublished data); (6) rarely in hypothyroidism (147); (7) rarely in mitochondrial disorders (98); (8) a genetic form of congenital muscle fiber-type disproportion with additional muscle biopsy findings of myofibrillar lysis but not myofiber necrosis, and cardiomyopathy (09); (9) fetal alcohol syndrome (87); (10) rigid spine syndrome (53; 137; 150); (11) oculocerebrorenal disease of Lowe (71); (12) cerebellar hypoplasia (125; 126) and other cerebral dysgeneses with involvement of posterior fossa neural structures (48; 97); (13) Emery-Dreifuss X-linked muscular dystrophy (type I fiber atrophy or hypoplasia is a typical feature of the muscle biopsy, and some patients also have type I fiber predominance or frank congenital muscle fiber-type disproportion) (162); (14) coexistence of congenital muscle fiber-type disproportion with minicore myopathy (63); and (15) with centronuclear myopathy (01).

Over 60% of children with hypotonia and type I muscle fiber predominance, perhaps an incompletely expressed congenital muscle fiber-type disproportion, have central nervous system disease (75).

Table 1. Differential Diagnosis of Congenital Muscle Fiber-Type Disproportion Syndrome

Associated condition or disease	Reference
• Isolated congenital myopathy	(45; 17; 20; 66; 15; 59; 69)
• Centronuclear myopathy	(109; 79; 37; 117)
• Nemaline rod myopathy (with ACTA1, TPM2, TPM3, SEPM1 or NEB1 mutations)	(124; 59; 145; 101; 46; 77; 94; 164; 34; 83; 100; 115; 13; 153; 88)
• Infantile myotonic dystrophy	(135; 04; 154)
• Emery-Dreifuss muscular dystrophy	(162)
• Infantile facioscapulohumeral muscular dystrophy	(16)
• Ulrich disease (collagen VI mutation)	(136)
• Myofibrillar lysis and cardiomyopathy	(09)
• Myofibrillar myopathy (with ACTA1 mutation)	(140)
• Calpain 3 deficiency	(160)
• Distal myopathy (autosomal dominant MYH7 mutation)	(121)
• Globoid cell leukodystrophy (Krabbe disease)	(87; 40; 84)
• Laminopathy with LMNA gene mutations in the lamin A/C protein)	(122)
• Minicore myopathy	(63)
• Multiple sulfatase deficiency	(152; 82)
• Pompe disease (glycogenosis II)*	(87)
• Cori-Forbes disease (glycogenosis III)*	(87)
• Phosphorylase-B-kinase deficiency (glycogenosis IX)*	(Sarnat et al unpublished data)
• Phosphoglyceromutase deficiency*
• Hypothyroidism*	(147)
• Diabetes mellitus, insulin-resistant form	(161; 30)
• Mitochondrial cytopathy*	(98)
• Fetal alcohol syndrome	(87)
• Rigid spine syndrome	(53; 137; 150)
• PHOX2B mutation	(67)
• RYR1 mutation	(33; 166)
• MYH7 mutation (and myosin excess)	(105; 29; 107)
• MYH2 mutation	(165)
• SPEG mutation	(55)
• MYL2 mutation	(86)
• TPM3 mutation	(03; 11)
• MAP3K20 mutation	(01)
• ZAK kinase mutation	(159)
• Oculocerebrorenal disease of Lowe	(71)
• Cerebellar hypoplasia and other dysgeneses of brainstem or cerebellum, diabetes mellitus, insulin-resistant*	(125; 126; 48; 97; 163; 70)
• Hypertrophic polyneuropathy	(44)
• Spinal muscular atrophy	(52)
* rare or inconstant

Postmortem examination of the spinal cord and peripheral nerves of a few patients showed no abnormalities, and the number and morphology of motor neurons in particular were normal (149; Sarnat unpublished data). Atrophy and degeneration of the medial neuronal group of the ventral horn in lumbosacral segments was found in a patient with congenital muscle fiber-type disproportion and rigid spine syndrome (150).

An association was made in a child with congenital muscle fiber-type disproportion who had congenital melanocytic nevi that underwent malignant degeneration to melanoma (138).

In some of the metabolic disorders cited in Table 1, the congenital muscle fiber-type disproportion may not be as "pure" as in the uncomplicated genetic forms of the disease in that the ratio of fiber type I and II may be somewhat less than 80%, not all of the type I fibers may be hypoplastic, or the small type I fibers may be angular rather than retaining the normal polygonal contour. Whether these conditions should be classified as congenital muscle fiber-type disproportion or whether strict and absolute criteria should be upheld varies among authors.

Genetic etiologies. Several genetic mutations are now recognized in which congenital muscle fiber-type disproportion is a component (28; 23; 54; 102). The SEPN1 gene at locus 1p36-p35 is associated with insulin resistance in diabetic children (30), and congenital muscle fiber-type disproportion was previously known to be associated with insulin resistance (161). In some cases of central congenital hypoventilation syndrome, the PHOX2B gene has been implicated (67). In nemaline myopathy with congenital muscle fiber-type disproportion, ACTA1 (skeletal alpha-actin) and TPM3 (tropomyosin alpha-3 chain) at 1q22-q23 are now well documented (31; 101; 46; 157; 94; 100; 13; 54; 153). The latter has been confused clinically with congenital myasthenia gravis (94). Other genes implicated in congenital muscle fiber-type disproportion include beta-tropomyosin (TPM2) (14; 34; 115). Loss of function TPM3 mutation, which as with TPM2 mutation, can also present in the muscle biopsy as a “cap myopathy” (164; 83; 03); missense changes in slow alpha-tropomyosin encoded by the TPM3 gene is an autosomal recessive trait in congenital muscle fiber-type disproportion but may result in only a mild clinical phenotype (03; 102) or a combination with cap disease and nemaline rods histopathologically and a more severe clinical course (11). SEPN4 and beta-myosin (MYH7) exhibit with muscle biopsy findings of myosin excess or “storage” (105; 29; 83). Testing is available for these genes. Some, such as the cap myopathies due to TPM mutations, can have secondary features of neuromuscular transmission defects and, thus, resemble myasthenia; these are important to recognize because they may respond to cholinesterase inhibitors (115).

Among the most important genetic mutations demonstrated to cause the congenital muscle fiber-type disproportion phenotype are those exhibiting molecular structural alterations in the contractile proteins. Those affecting actin filaments and tropomyosin were noted in the preceding paragraph. Myosin heavy chain (MYH), another major contractile component of muscle, is also demonstrated to be affected in other cases with normal actin. MYH7 is a beta-myosin gene that clinically causes a distal myopathy with autosomal dominant transmission (121; 107). This MYH7 myopathy may present clinically in infancy with diffuse weakness and hypotonia of axial and appendicular muscles; congenital muscle fiber-type disproportion is seen pathologically in the muscle biopsy, and exon skipping has been demonstrated by whole exome sequencing (107). A novel MYH2 mutation causes ophthalmoplegia and facial weakness in patients and family members, with muscle biopsy demonstrating absence of type IIA myofibers and genetic analysis showing exon skipping (165). The LMNA gene, which is also associated with Emery-Dreifuss muscular dystrophy, limb-girdle dystrophy, and autosomal recessive axonal neuropathy, can be expressed as congenital muscle fiber-type disproportion in the muscle biopsy (122).

RYR1 mutations, transmitted as an autosomal recessive trait, are another genetic association with congenital muscle fiber-type disproportion that has been documented in several families; some of these patients also have centronuclear myopathy, but in others, the sarcolemmal nuclei remain peripheral with only occasional scattered centronuclear fibers (33; 166). Another autosomal recessive mutation in the kinase ZAK may be associated with congenital fiber-type disproportion (159). Still another mutation, MYH7 of autosomal dominant transmission, associates congenital muscle fiber-type disproportion with myosin increase or storage in the muscle (105). In other cases, the specific mutation or deletion is unknown, but the chromosomal locus has been identified, as in the 1p36 deletion syndrome with congenital muscle fiber-type disproportion (104).

The association of congenital muscle fiber-type disproportion with cardiomyopathy is consistent with certain specific genetic mutations, such as MYL2, SPEG, and ACTA1 (86; 55; 88; 102). Fiber-type disproportion also can be a minor component of some congenital muscular dystrophies with myofiber degeneration as a more prominent component in the muscle biopsy (19).

The phenotype-genotype correlation is, therefore, highly variable because congenital muscle fiber-type disproportion is a multietiological syndrome rather than a single disease and can be due to either genetic causes or to developmental malformation of the brain, particularly the cerebellum (112).

Fetal development pathogenesis. Congenital muscle fiber-type disproportion is probably a developmental disorder of muscle arising during the histochemical stage of muscle maturation, between 20 and 28 weeks' gestation, though the disparate growth of myofibers may continue in late fetal life (130). Congenital muscle fiber-type disproportion is not, however, a simple arrest in a normal stage of muscle ontogenesis (129; 130; 131). Disturbances in muscle fiber-type differentiation occur in congenital neuropathies beginning in fetal life, such as congenital hypomyelinating neuropathy due to genetic SOX10 or myelin protein zero (MPZ0) mutations, but this is more of a delayed histochemical differentiation than congenital muscle fiber-type disproportion (151). Congenital muscle fiber-type disproportion does occur, however, in infantile polyneuropathies (44; 60), occasionally in spinal muscular atrophy (52), and in globoid cell leukodystrophy (Krabbe disease), though usually in a stage when the CNS white matter is more affected than peripheral nerve (40; 84). Amongst the congenital muscular dystrophies, the most frequent associations are with neonatal myotonic dystrophy, and it has been shown to be a component of Ullrich muscular dystrophy due to a defect in collagen VI (136). Calpain-3 deficiency causes myopathy and may also present as fiber-type disproportion (160). Fiber-type disproportion also is found in many congenital centronuclear myopathies (142; 117). Defects of excitation-contraction components in extraocular muscles may occur in congenital muscle fiber-type disproportion as with several other congenital myopathies (139). Congenital ptosis may accompany ophthalmoplegia in these cases because the striated levator palpebrae muscle of the upper eyelid is also involved, and both this muscle and the smooth Müller muscle are needed to act synergistically for complete retraction of the upper eyelid (131).

The association with cerebellar hypoplasia suggests that suprasegmental influences on the motor neuron during the histochemical stage of muscle maturation may dictate the aberration in differential growth and maturation of types I and II myofibers (125; 126). The bulbospinal tracts form before 20 weeks’ gestation and, during the critical histochemical period of 20 weeks to 28 weeks, they form important relations with motor neurons and spinal interneurons because of the sprouting of axonal collaterals, synaptogenesis, and myelination. The cerebellum projects no direct descending "cerebellospinal" fibers. Efferent axons of the cerebellar nuclei synapse in the red, vestibular, inferior olivary, and tegmental reticular nuclei, however. All of these structures mediate cerebellar impulses through descending bulbospinal projections. The corticospinal tract, by contrast, has few axonal ramifications or synaptic contacts at this age and is still completely unmyelinated and probably nonfunctional (127); ascending cerebellar connections with the cerebral cortex, via relay in the thalamus, do not, therefore, likely influence the developing motor unit. Hypotonia is a constant feature of human cerebellar hypoplasia (132); experimental studies in the monkey demonstrate that the mechanism is diminished fusimotor activity by spinal gamma motor neurons (50). In animals, repetitive stimulation of motor nerves results in conversion of type II muscle fibers to type I (73; 123); hence, the pathogenesis of congenital muscle fiber-type disproportion in cerebellar hypoplasia may be abnormal suprasegmental stimulation of spinal motor neurons (125; 126). Congenital muscle fiber-type disproportion does not occur in children with spastic or hypotonic diplegia due to cortical or corticospinal tract lesions in the perinatal period (124).

The pathogenesis and pathophysiology of congenital muscle fiber-type disproportion in the various metabolic diseases that are not primary myopathies are unknown. Congenital muscle fiber-type disproportion occurs in some cases of Moebius syndrome, consistent with a developmental brainstem disorder (147). The basis for congenital muscle fiber-type disproportion as an isolated congenital myopathy is uncertain, but it is likely an autosomal recessive trait for which the genetic mutation is not yet identified.

The finding of congenital muscle fiber-type disproportion in a family with a balanced chromosomal translocation of t(10; 17) suggested that a genetic locus responsible for the myopathy might be on one of these chromosomes (49), but the consistent association of congenital muscle fiber-type disproportion with Krabbe leukodystrophy, in which chromosome 14 is implicated by linkage studies, suggests another locus if indeed the genetic defect is directly responsible for the myopathy.

The great majority of cases of congenital muscle fiber-type disproportion are sporadic, but some familial cases appear to be transmitted as an autosomal dominant trait (68), and other families with similarly involved siblings suggest an autosomal recessive inheritance (44). Two brothers with a defect of the insulin receptor gene have a 91% to 95% reduction in receptor kinase activity; their father shows a similar 70% reduction in the insulin receptor kinase with an Arg1174-Gln mutation. The mother, however, also shows a genetic defect related to insulin receptor kinase, with a point mutation at the last base pair in exon 17 (70). This molecular genetic defect of alternative splicing of exon 17 and a missense mutation in exon 20 of the insulin receptor gene is expressed as insulin-resistant diabetes mellitus and congenital muscle fiber-type disproportion (161; 163).

Abnormal actin filaments due to a genetic mutation are found in some cases of congenital muscle fiber-type disproportion (76). A defect in tropomyosin 3 (TPM3) is more frequent than previously thought and shows a stronger association with fiber-type disproportion (77). The gene of TPM3 is mutated in some cases of nemaline myopathy, which constantly has fiber-type disproportion as a histopathological feature of muscle. ACTA1 is another gene expressed in actin filaments in which mutations are associated with nemaline rod disease including intranuclear rods, central core disease, myofibrillar myopathy, and congenital muscle fiber-type disproportion (140).

Phosphoprotein B-50 is reported to be immunocytochemically demonstrable on the inner face of only the small myofibers of type I in congenital muscle fiber-type disproportion (58). The significance of this finding is uncertain. Phosphoprotein B-50 may serve a local function involving transmembrane signaling by means of calmodulin binding or phosphorylation, but this role still does not explain the pathogenesis of congenital muscle fiber-type disproportion (58).

In rigid spine myopathy, a gene has been identified as mutated at the 1p35-36 locus (90; 91; 92). Though some authors characterize this myopathy as a “muscular dystrophy,” it is not a necrotizing myopathy; hence, it does not fulfill the criteria of a true dystrophy. In addition to muscular rigidity in axial muscles, a restrictive respiratory syndrome is characteristic (91; 92). The congenital muscle fiber-type disproportion in these cases is not always classical and may be partial, with uniform smallness of type I myofibers but without the other histopathological criterion of type I predominance (Dawson in preparation). In a family, a father and son both had congenital muscle fiber-type disproportion, and the father developed rigid spine syndrome in adult life (150). Another mechanism of the congenital muscle fiber-type disproportion in rigid spine syndrome may be altered motor unit stimulation by spinal interneurons, similar to cerebellar hypoplasia.

In multiple sulfatase deficiency, the defective SEPN1 gene encodes selenoprotein-N (82). Not all cases of this metabolic disease show congenital muscle fiber-type disproportion, however.

Many, though not all, infants with mitochondrial cytopathies, including Leigh encephalopathy, show congenital muscle fiber-type disproportion as a histopathological feature, but whether the hypotonia and weakness in these cases is due to myopathy or encephalopathy is not certain (Sarnat unpublished data).

Phylogenetically, congenital muscle fiber-type disproportion is the normal condition of rodents such as the rat, but the evolutionary relevance to the human disorder remains speculative (134).

Differential diagnosis

The clinical suspicion of congenital muscle fiber-type disproportion is often made on the basis of clinical features and morphology of the face and head; other cases are diagnosed by muscle biopsy for infantile hypotonia and weakness. The diagnosis of congenital muscle fiber-type disproportion must be confirmed by muscle biopsy; clinical features and other laboratory tests are not diagnostic.

Because congenital muscle fiber-type disproportion is a syndrome, the specific diseases with which it is associated must be excluded: myotonic muscular dystrophy, nemaline rod myopathy, glycogenoses, Krabbe leukodystrophy, Lowe disease, rigid spine syndrome, cerebellar hypoplasia, and fetal alcohol syndrome. The muscle biopsy alone does not distinguish these disorders except for nemaline rod myopathy and glycogenosis II.

The muscle biopsy of congenital muscle fiber-type disproportion with centronuclear fibers might be confused with that of X-linked myotubular myopathy, but many histological and histochemical features distinguish the two, including the strong immunoreactivity for vimentin and desmin in myotubular myopathy and the expression of desmin alone in some but not all cases of congenital muscle fiber-type disproportion (79; 128; 129).

The muscle biopsy of infantile myotonic dystrophy showing congenital muscle fiber-type disproportion may be indistinguishable from other causes of congenital muscle fiber-type disproportion or may show maturational arrest in various stages of muscle ontogenesis (135).

Perinatal denervation of muscle, such as in infantile spinal muscular atrophy (Werdnig-Hoffmann disease), also shows two populations of fiber sizes, but the hypertrophic fibers are grouped rather than scattered and are type I fibers rather than type II. Ultrastructurally, the sleeves of empty basement membranes projecting from the surface of myofibers in spinal muscular atrophy are not found in congenital muscle fiber-type disproportion (168). Atrophic muscle fibers in denervate neurogenic atrophy often have an angular contour in cross-section, whereas the hypoplastic type I fibers in congenital muscle fiber-type disproportion retain the normal polygonal shape.

A congenital familial myopathy involving an infant girl and her mother was described as type II fiber hypoplasia and type I fiber predominance (95). This nonprogressive and nondegenerative myopathy is not, however, congenital muscle fiber-type disproportion by definition, even though many clinical features, including facial weakness, are similar.

Diagnostic workup

No molecular genetic marker of congenital muscle fiber-type disproportion exists because of multiple etiologies, both genetic and developmental. Thus, the diagnosis of congenital muscle fiber-type disproportion was traditionally a histopathological finding in the muscle biopsy with a characteristic histochemical pattern of the ratio and sizes of the two major myofiber types (133). The discovery of many genetic mutations in congenital muscle fiber-type disproportion may enable in the near future primary genetic diagnosis in blood of specific point mutations or identification of mutant proteins, which is a less invasive method than muscle biopsy (23; 13; 54). Though “reverse fiber type disproportion” in muscle biopsy is published as a metabolic response to incremental exercise, with a 75% predominance of type II myofibers (35), this is not true congenital muscle fiber-type disproportion. In this regard, type II fibers are more variable in size in relation to exercise and undergo work hypertrophy or disuse atrophy more readily than type I fibers (133). This important distinction requires knowledge and experience by the pathologist reporting the muscle biopsy.

The serum creatine kinase is nearly always normal in congenital muscle fiber-type disproportion, though mild transient elevations are reported in a few patients (24). More constant increases in serum creatine kinase may occur in congenital muscle fiber-type disproportion secondary to metabolic diseases and are reported in a few familial cases without identified metabolic defects (43).

The EMG is usually normal or shows mild, nonspecific myopathic features (43; 24; 118). A reduced interference pattern with complex high-amplitude motor unit potentials is described in some patients (78). Fibrillations, positive sharp waves, and other signs of denervation of muscle are described only rarely, including in the rigid spine syndrome (150). Single fiber EMG in congenital muscle fiber-type disproportion is normal or mildly myopathic (119). It is important to identify secondary neuromuscular transmission defects that are potentially treatable (115). ECG is recommended for cardiomyopathy, even if no cardiac murmur or other clinical evidence of heart disease is evident (93).

The muscle biopsy is obligatory and diagnostic of this condition. The "disproportion" involves two aspects: size and histochemical fiber type. There is a predominance of 80% or more of small myofibers that are uniformly type I; the remaining hypertrophic fibers are type II, particularly subtype IIb (15; 124; 05; 59). A detailed morphometric study including comparisons of repeat muscle biopsies at different ages is provided by Iannaccone and colleagues (59). The reverse pattern (small type II fibers and large type I fibers) is not congenital muscle fiber-type disproportion. The distribution of the two populations of fibers is relatively uniform and involves all fascicles. Necrosis and myofiber degeneration and regeneration are not found. Perimysial connective tissue may be mildly increased or normal. In some cases, probably constituting less than 20%, between 10% and 70% of myofibers of both sizes have central nuclei, but other cytoarchitectural alterations are rare except for occasional "moth-eaten" fibers with zones of disorganized myofilaments (66; 61; 124). The presence of nemaline rods identifies the congenital muscle fiber-type disproportion as nemaline rod myopathy and the subtype IIb hypertrophic fibers are often absent in nemaline myopathy, the hypertrophic fibers being mainly IIc (145). Congenital muscle fiber-type disproportion in metabolic myopathies may be accompanied by myopathic changes characteristic of those diseases, such as vacuoles in glycogenesis II. Minicores may coexist in some familial forms of congenital muscle fiber-type disproportion (63). Discoveries in genetic mutations and mechanisms still require muscle biopsy to demonstrate and clarify the pathogenicity of gene variants as well as directing molecular analysis (141).

The congenital muscle fiber-type disproportion or fiber-type preponderance associated with cerebellar hypoplasia lacks distinctive features that distinguish the muscle biopsy from congenital muscle fiber-type disproportion as an idiopathic congenital myopathy (125). The shape of the small type I fibers is a secondary feature that helps distinguish type I hypoplasia of true congenital muscle fiber-type disproportion from acquired type I atrophy: in pure congenital muscle fiber-type disproportion, the small type I fibers retain their polygonal contour in transverse section, whereas secondarily atrophic fibers are more often sharply angular.

In some cases, genetic studies for particular mutations are indicated. Examples include the genes associated with nemaline myopathy, such as ACTA1 and TPM3 if nemaline rods are noted in the muscle biopsy, PHOX2B gene mutations, particularly if respiratory insufficiency is a prominent clinical feature, and SEPN1 if insulin resistant diabetes mellitus is the presentation. MYH genes of the myosin heavy chain also merit genetic analysis by whole exon sequencing to demonstrate exon skipping in selected cases.

Media

References

01: Ahmad I, Khan A, Noor UIAH, et al. A novel MAP3K20 mutation causing centronuclear myopathy-6 with fiber-type disproportion in a Pakistani family. J Hum Genet 2023;68(2):107-9. PMID 36217027
02: Akiyama C, Nonaka T. A follow-up study of congenital non-progressive myopathies. Brain Dev 1996;18:404-8. PMID 8891237
03: Araujo Martins Moreno C, de Paula Estephan E, Fappi A, et al. Congenital fiber type disproportion caused by TPM3 mutation: a report of two atypical cases. Neuromuscul Disord 2020;30(1):54-8. PMID 31866162
04: Argov Z, Gardner-Medwin D, Johnson MA, Mastaglia FL. Congenital myotonic dystrophy: fiber type abnormalities in two cases. Arch Neurol 1980;37:693-6. PMID 7436809
05: Argov Z, Gardner-Medwin D, Johnson MA, Mastaglia FL. Patterns of muscle fiber-type disproportion in hypotonic infants. Arch Neurol 1984;41:53-7. PMID 6689888
06: Avrova SV, Karpicheva OE, Rysev NA, et al. The reason for the low Ca2+-sensitivity of thin filaments associated with the Glu41Lys mutatin in the TPM2 gene is “freezing” of tropomyosin near the outer domain of actin and inhibition of actin monomer switching off during the ATPase cycle. Biochem Biophys Res Commun 2018;502(2):209-14. PMID 29792862
07: Baccetti T, Defraia E, Donati MA. Craniofacial abnormalities associated with congenital fiber type disproportion myopathy. J Clin Pediatr Dent 1997;21:167-71. PMID 9484111
08: Banwell BL, Becker LE, Jay V, Taylor GP, Vajsar J. Cardiac manifestations of congenital fiber-type disproportion myopathy. J Child Neurol 1999;14:83-7. PMID 10073429
09: Barth PG, Wanders RJ, Ruitenbeek W, et al. Infantile fibre type disproportion, myofibrillar lysis and cardiomyopathy: a disorder in three unrelated Dutch families. Neuromuscul Disord 1998:8(5):296-304. PMID 9673982
10: Bartholomeus MG, Gabreels FJ, ter Laak HJ, van Engelen BG. Congenital fibre type disproportion a time-locked diagnosis: a clinical and morphological follow-up study. Clin Neurol Neurosurg 2000;102:97-101. PMID 10817896
11: Bevilacqua JA, Contreras JP, Trangulao A, et al. Novel autosomal dominant TPM3 mutation causes a combined congenital fibre type disproportion-cap disease histological pattern. Neuromusc Disord 2022;32(8):687-91. PMID 35688744
12: Bigner DR, Rijhsinghani A, Yankowitz J. Congenital fiber-type disproportion presenting antenatally with clubfoot and hydramnios. Gynecol Obstet Invest 2000;49(4):275-6. PMID 10828713
13: Borovikov YS, Karpicheva OE, Simonyan AO, et al. The primary causes of muscle dysfunction associated with the point mutations in Tpm3.12; conformational analysis of mutant proteins as a tool for classification of myopathies. Int J Mol Sci 2018;19(12). PMID 30544720
14: Brandis A, Aronica E, Goebel HH. TPM2 mutation. Neuromuscul Disord 2008;18(12):1005. PMID 18789687
15: Brooke MH. Congenital fibre type disproportion. In: Kakulas BA, editor. Clinical Studies in Myology. Amsterdam: Excerpta Medica, 1973:147-59.
16: Brooke MH, Carroll JE, Ringel SP. Congenital hypotonia revisited. Muscle Nerve 1979;2(2):84-100. PMID 397413
17: Brooke MH, Engel WK. The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology 1969;19:591-605. PMID 5814304
18: Buisan F, de la Varga O, Flores M, Sánchez-Ruano J. Anaesthetic management of a paediatraic patient with congenital fibre-type disproportion myopathy. Rev Esp Anestesiol Reanim 2018;65(8):469-72. PMID 29699707
19: Butterfield RJ. Congenital muscular dystrophy and congenital myopathy. Continuum (Minneap) 2019;25(6):1640-61. PMID 31794464
20: Caille B, Fardeau M, Harpey JP. Hypotonie congenitale avec atteinte selective des fibres musculaires de type 1. A propos de deux observations. Arch Fr Pediatr 1971;28:205-20. PMID 5581478
21: Camacho A, Villarejo A, Simon R, Mateos F, Cabello A. Clinical and histologic changes in the follow-up of a congenital myopathy. Pediatr Neurol 2005;33(2):139-41. PMID 16087062
22: Carpenter S, Karpati G. Pathology of Skeletal Muscle. 2nd ed. New York: Oxford University Press, 2001:404-6.
23: Cassandrini D, Trovato R, Rubegni A, et al. Congenital myopathies: clinical phenotypes and new diagnostic tools. Ital J Pediatr 2017;43(1):101. PMID 29141652
24: Cavanagh NP, Lake BD, McMeniman P. Congenital fibre type disproportion myopathy. A histological diagnosis with an uncertain clinical outlook. Arch Dis Child 1979;54:735-43. PMID 507896
25: Chang JH, Jong YI, Mak SC, Chiang CH. Congenital fiber type disproportion: report of one case. Acta Paediatr Sin 1990;31:366-72. PMID 2284944
26: Claeys KG. Congenital myopathies: an update. Dev Med Child Neurol 2020;62(3):297-302. PMID 31578728
27: Clancy RR, Kelts KA, Oehlert JW. Clinical variability in congenital muscle fibre-type disproportion. J Neurol Sci 1980;46:257-66. PMID 7381515
28: Clarke NF. Congenital fiber-type disproportion. Semin Pediatr Neurol 2011a;18(4):264-71. PMID 22172422
29: Clarke NF. Congenital fibre type disproportion–a syndrome at the crossroads of the congenital myopathies. Neuromusc Disord 2011b;21(4);252-3. PMID 21420627
30: Clarke NF, Kidson W, Quijano-Roy S, et al. SEPN1: associated with congenital fiber-type disproportion and insulin resistance. Ann Neurol 2006;59(3):546-52. PMID 16365872
31: Clarke NF, Kolski H, Dye D, et al. Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol 2008;63(3):329-37. PMID 18300303
32: Clarke NF, North KN. Congenital fiber type disproportion--30 years on. J Neuropathol Exp Neurol 2003;62(10):977-89. PMID 14575234
33: Clarke NF, Waddell LB, Cooper ST, et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum Mutat 2010;31(7):E1544-50. PMID 20583297
34: Clarke NF, Waddell LB, Sie LT, et al. Mutations in TPM2 and congenital fibre type disproportion. Neuromusc Disord 2012;22(11):955-8. PMID 22832343
35: Cooper CB, Dolezal B, Riley M, Verity MA, Shieh PB. Reverse fiber type disproportion: a distinct metabolic myopathy. Muscle Nerve 2016;54(1):86-93. PMID 26600317
36: Curless RG, Nelson MB. Congenital fiber-type disproportion in identical twins. Ann Neurol 1977;2:455-9. PMID 569460
37: Danon MJ, Giometti CS, Malaligod JR, Swisher C. Sequential muscle biopsy changes in a case of congenital myopathy. Muscle Nerve 1997;20:561-9. PMID 9140362
38: Darsee JR, Miklozek CL, Heymsfield SB, Hopkins LC Jr, Wenger NK. Mitral valve prolapse and ophthalmoplegia: a progressive cardioneurologic syndrome. Ann Intern Med 1980;92(6):735-41. PMID 6992676
39: DeChene ET, Kang PB, Beggs AH. Congenital Fiber-Type Disproportion. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. Seattle (WA): University of Washington, Seattle, 2008.
40: Dehkharghani F, Sarnat HB, Brewster MA, Roth SI. Congenital muscle fiber type disproportion in Krabbe's leukodystrophy. Arch Neurol 1981;38:585-91. PMID 7271538
41: Dinn JJ, O'Doherty N. Congenital type II fibre deficient myopathy. Ir J Med Sci 1980;149(2):53-8. PMID 7372448
42: Dubowitz V. Muscle Disorders in Childhood. 2nd ed. Philadelphia, London: WB Saunders, 1995:166-7.
43: Eisler T, Wilson JH. Muscle fiber-type disproportion: report of a family with symptomatic and asymptomatic members. Arch Neurol 1978;35:823-6. PMID 718485
44: Fardeau M, Harpey JP, Caille B. [Congenital desproportion of various types of muscle fiber, with relative small size of type I fibers. Morphological documents on muscle biopsies in 3 members of the same family] Rev Neurol (Paris) 1975;131(11):745-66. PMID 130671
45: Farkas-Bargeton E, Aicardi J, Chevrie JJ, Thieffry S. Apport des techniques histoenzymologiques a l'étude des hypotonies congénitales. Rev Neurol (Paris) 1968;119:513-24. PMID 4310071
46: Feng JJ, Marston S. Genotype-phenotype correlations in ACTA1 mutations that cause congenital myopathies. Neuromusc Disord 2009;19(1):6-16. PMID 18976909
47: Fujita K, Nakano S, Yamamoto H, et al. An adult case of congenital fiber type disproportion (CFTD) with cardiomyopathy]. Rinsho Shinkeigaku 2005;45(5):380-2. PMID 15960177
48: Garcia-Alix A, Blanco D, Cabanas H, Garcia Sanchez P, Pellicer A, Quero J. Early neurological manifestations and brain anomalies in Marden-Walker syndrome. Am J Med Genet 1992;44:41-5. PMID 1519648
49: Gerdes AM, Petersen MB, Schroder HD, Wulff K, Brondum-Nielsen K. Congenital myopathy with fiber type disproportion: a family with a chromosomal translocation t(10;17) may indicate candidate gene regions. Clin Genet 1994;45(1):11-6. PMID 7908614
50: Gilman S. The mechanism of cerebellar hypotonia: an experimental study in the monkey. Brain 1969;92:621-38. PMID 4241080
51: Gineste C, Laporte J. Therapeutic approaches in different congenital myopathies. Curr Opin Pharmacol 2023;68:102328. PMID 36512981
52: Glick G, Shapira Y, Stern A, Blank A, Rosenmann E. Congenital muscle fiber-type disproportion myopathy: a follow up study of twenty cases [abstract]. Ann Neurol 1984;16:405-6.
53: Goebel HH, Lenard HG, Gorke W, Kunze K. Fibre type disproportion in the rigid spine syndrome. Neuropadiatrie 1977;8:467-77. PMID 579444
54: Gonorazky HD, Bönnemann CG, Dowling JJ. The genetics of congenital myopathies. Handb Clin Neurol 2018;148:549-64. PMID 29478600
55: Gurgel-Giannetti J, Souza LS, Messina de Padua Andrade GF, et al. A novel SPEG mutation causing congenital myopathy with fiber size disproportion and dilated cardiomyopathy with heart transplantation. Neuromuscul Disord 2021;31(11):1199-206. PMID 34742623
56: Haltia M, Somer H, Rehunen S. Congenital fiber type disproportion in an adult: a morphometric and microchemical study. Acta Neurol Scand 1988;78:65-71. PMID 2972157
57: Hernandez M, Ricoy JR, Santolaya JM, Escudero R. Miopatías congénitas con hipotrofia de fibras tipo I. An Esp Pediat 1978;11:471-84. PMID 697216
58: Heuss D, Schlotzer-Schrehardt U. Subcellular localization of phosphoprotein B-50 in regenerating muscle. An immuno-electron microscopic study. Neurol Res 1998;20:360-4. PMID 9618702
59: Iannaccone ST, Bove KE, Vogler CA, Buchino JJ. Type I fiber size disproportion: morphometric data from 37 children with myopathic neuropathic, or idiopathic hypotonia. Pediatr Pathol 1987;7:395-419. PMID 2451237
60: Igarashi M. Floppy infant syndrome. J Clin Neuromuscul Dis 2004;6(2):69-90. PMID 19078754
61: Inokuchi T, Umezaki H, Santa T. A case of type I muscle fiber hypotrophy and internal nuclei. J Neurol Neurosurg Psychiatry 1975;38:475-82. PMID 168319
62: Jaffe M, Shapira J, Borochowitz Z. Familial congenital fiber type disproportion (CFTD) with an autosomal recessive inheritance. Clin Genet 1988;33:33-7. PMID 3342545
63: Jongpiputvanich S, Walsh PJ, Kakulas BA. Minicores and congenital fibre-type disproportion observed in a family. J Paediatr Child Health 2008;31(3):253-7. PMID 7669390
64: Jungbluth H, Muntoni F. Therapeutic aspects in congenital myopathies. Semin Pediatr Neurol 2019;29:71-82. PMID 31060727
65: Jungbluth H, Ochala J, Treves S, Guatel M. Current and future therapeutic approaches to the congenital myopathies. Semin Cell Dev Biol 2017;64:191-200. PMID 27515125
66: Karpati G, Carpenter S, Nelson RF. Type I muscle fiber atrophy and central nuclei and myotube-like structures. J Neurol Sci 1971;10:489-500. PMID 4910660
67: Khan A, Sarnat HB, Spaetgens R. Congenital muscle fiber-type disproportion in a patient with congenital central hypoventilation syndrome due to PHOX2B mutations. J Child Neurol 2008;23(7):829-31. PMID 18658083
68: Kim WK, Choi BO, Cheon HY, et al. Muscle fiber-type disproportion with an autosomal dominant inheritance. Yonsei Med J 2000;41:281-4. PMID 10817032
69: Kissiedu J, Prayson RA. Congenital muscle fiber type disproportion. J Clin Neurosci 2016;26:136-7. PMID 26526626
70: Klein HH, Muller R, Vestergaard H, Pedersen O. Implications of compound heterozygous insulin receptor mutations in congenital muscle fibre type disproportion myopathy for the receptor kinase activation. Diabetologia 1999;42:245-9. PMID 10064106
71: Kohyama J, Niimura F, Kawashima K, Iwakawa Y, Nonaka I. Congenital fiber type disproportion myopathy in Lowe syndrome. Pediatr Neurol 1989;5:373-6. PMID 2604802
72: Kubota M, Kanda E, Ida K, Sakakihara Y, Hayashi M. Severe gastrointestinal dysmotility in a patient with congenital myopathy: causal relationship to decrease of interstitial cells of Cajal. Brain Devel 2005;27:447-50. PMID 16122635
73: Kugelberg E. Adaptive transformation of rat soleus motor units during growth. Histochemistry and contraction speed. J Neurol Sci 1976;27:269-89. PMID 131182
74: Kula RW, Sher JH, Shafiq SA, Hardy-Stashin J. Variability of clinical and pathological manifestations in familial fiber type disproportion. Trans Am Neurol Assoc 1980;105:416-8.
75: Kyriakides T, Silberstein JM, Jongpiputvanich S, et al. The clinical significance of type 1 fiber predominance. Muscle Nerve 1993;16(4):418-23. PMID 8455657
76: Laing NG, Clarke NF, Dye DE, et al. Actin mutations are one cause of congenital fibre type disproportion. Ann Neurol 2004;56(5):689-94. PMID 15468086
77: Lawlor MW, Dechene ET, Roumm E, et al. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 2010;31:176-83. PMID 19953533
78: Lenard HG, Goebel HH. Congenital fibre type disproportion. Neuropadiatrie 1975;6:220-31.
79: Lo WD, Barohn RJ, Bobulski RJ, Kean J, Mendill JR. Centronuclear myopathy and type-1 hypotrophy without central nuclei. Distinct nosologic entities. Arch Neurol 1990;47:273-6. PMID 2310312
80: Loren GJ, Karpinski NC, Mubarak SJ. Clinical implications of clubfoot histopathology. J Pediatr Orthop 1998;18:765-9. PMID 9821133
81: Maani N, Karolczak S, Dowling JJ. Genetic therapy for congenital myopathies. Curr Opin Neurol 2021;34(5):727-37. PMID 34267051
82: Macaulay RJ, Lowry NJ, Casey RE. Pathologic findings of multiple sulfatase deficiency reflect the pattern of enzyme deficiencies. Pediatr Neurol 1998;19(5):372-6. PMID 9880143
83: Maggi L, Scoto M, Cirak S, et al. Congenital myopathies–clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom. Neuromusc Disord 2013;23(3):195-205. PMID 23394784
84: Marjanovic B, Cvetkovic D, Dozic S, Todorovic S, Djuric M. Association of Krabbe leukodystrophy and congenital fiber type disproportion. Pediatr Neurol 1996;15(1):79-82. PMID 8858709
85: Marolda M. Congenital fiber type disproportion in two sisters. A clinical and histopathological study. Acta Neurol (Napoli) 1992;14:398-407. PMID 1293983
86: Marttila M, Win W, Al-Ghamdi F, et al. MYL2-associated congenital fiber-type disproportion and cardiomyopathy with variants in additional neuromuscular disease genes; the dilemma of panel testing. Cold Spring Harb Mol Case Stud 2019;5(4):a004184. PMID 31127036
87: Martin JJ, Clara R, Ceuterick C, Joris C. Is congenital fibre type disproportion a true myopathy. Acta Neurol Belg 1976;76:335-44. PMID 1070214
88: Matsumoto A, Tsuda H, Furui S, et al. A case of congenital fiber-type disproportion syndrome presenting dilated cardiomyopathy with ACTA1 mutation. Mol Genet Genomic Med 2022;10(9):e2008. PMID 35757965
89: Mizuno Y, Komiya K. A serial muscle biopsy study in a case of congenital fiber-type disproportion associated with progressive respiratory failure. Brain Dev 1990;12:431-6. PMID 2240465
90: Moghadaszadeh B, Desguerre I, Topaloglu H, et al. Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36. Am J Hum Genet 1998;62(6):1439-45. PMID 9585610
91: Moghadaszadeh B, Petit N, Hu C, et al. Selenoprotein N: the culprit for congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Acta Myologica 2001a;20:104-9. PMID 11528383
92: Moghadaszadeh B, Petit N, Jaillard C, et al. Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 2001b;29(1):17-8. PMID 11528383
93: Moore AJ, Shevell MI, Poulin C, Rohlicek C. Cardiac involvement in congenital fiber type disproportion myopathy (abstract). Ann Neurol 2002;52:S153.
94: Munot P, Lashley D, Jungbluth H, et al. Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia. Neuromuscul Disord 2010;20(12):796-800. PMID 20951040
95: Muranaka H, Osari S, Fujita H, et al. Congenital familial myopathy with type 2 fiber hypoplasia and type 1 fiber predominance. Brain Dev 1997;19:362-5. PMID 9253491
96: Na SJ, Kim WK, Kim TS, et al. Comparison of clinical characteristics between congenital fiber type disproportion myopathy and congenital myopathy with type 1 fiber predominance. Yonsei Med J 2006;47(4):513-8. PMID 16941741
97: Nakagawa E, Ozawa M, Yamanouchi H, et al. Severe central nervous system involvement in a patient with congenital fiber-type disproportion myopathy. J Child Neurol 1996;11:71-3. PMID 8745394
98: Naumann M, Reiners K, Gold R, et al. Mitochondrial dysfunction in adult-onset myopathies with structural abnormalities. Acta Neuropathol 1995;89(2):152-7. PMID 7732787
99: Noda Y, Moki Y, Ishikita I, et al. Congenital fiber-type disproportion associated with aortic coarctation complex: a case report. No To Hattatsu 1990;22:88-90. PMID 2294956
100: Nowak KJ, Ravenscroft G, Laing NG. Skeletal muscle α-actin diseases (actinopathies): pathology and mechanisms. Acta Neuropathol 2013;125(1):19-32. PMID 22825594
101: North KN, Laing NG. Skeletal muscle alpha-actin diseases. Adv Exp Med Biol 2008;642:15-27. PMID 19181090
102: Ogasawara M, Nishino I. A review of major causative genes in congenital myopathies. J Hum Genet 2023;68(3):215-25. PMID 35668205
103: Oh SJ, Danon MJ. Nonprogressive congenital neuromuscular disease with uniform type I fibers. Arch Neurol 1983;40:147-50. PMID 6830453
104: Okamoto N, Toribe Y, Nakajima T, et al. A girl with 1p36 deletion syndrome and congenital fiber type disproportion myopathy. J Hum Genet 2002;47(10):556-9. PMID 12376748
105: Ortolano S, Tarrio R, Blanco-Arias P, et al. A novel MYH7 mutation links congenital fiber type disproportion and myosin storage myopathy. Neuromuscul Disord 2011;21(4):254-62. PMID 21288719
106: Owen JS, Kline LB, Oh SJ, Miles NE, Benton JW. Ophthalmoplegia and ptosis in congenital fiber type disproportion. J Pediatr Ophthalmol Strabismus 1981;18:55-60. PMID 7264853
107: Pajusalu S, Talvik I, Noormets K, et al. De novo exonic mutation in MYH7 gene leading to exon skipping in a patient with early onset muscular weakness and fiber-type disproportion. Neuromusc Disord 2016;26(3):236-9. PMID 26782017
108: Papadimas GK, Xirou S, Kararizou E, Papadopoulos C. Update on congenital myopathies in adulthood. Int J Mol Sci 2020;21(10):3694. PMID 32456280
109: Peyronnard JM, Charron L, Ninkovic S. Type 1 fiber atrophy and internal nuclei. A form of centronuclear myopathy. Arch Neurol 1982;39:520-4. PMID 6213218
110: Radke J, Sstenzel W, Goebel HH. Recently identified congenital myopathies. Semin Pediatr Neurol 2019;29:83-90. PMID 31060728
111: Rao TV, Koul RL, Inuwa IM. Congenital fiber-type disproportion myopathy with type I fiber predominance and type II fiber smallness and atrophy – a stereological analysis. Clin Neuropathol 2005;24:26-31. PMID 15696781
112: Ravenscroft G, Laing NG, Bönnermann CG. Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus. Brain 2015;138(Pt 2):246-68. PMID 25552303
113: Ricoy JR, Cabello A. Hypotrophy of type I fibres with central nuclei: recovery 4 years after diagnosis. J Neurol Neurosurg Psychiatry 1985;48:167-71. PMID 3981176
114: Rodenas S, Guo LT, Shelton GD. Myopathy associated with congenital fibre type disproportion in a young dog. J Comp Pathol 2012;147(4):486-90. PMID 22789857
115: Rodriguez Cruz PM, Sewry C, Beeson D, et al Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature. Neuromusc Disord 2014;24(12):1103-10. PMID 25127990
116: Rojiani AM, Cho ES. Neuropathologic applications of immunohistochemical fiber typing in the non-neoplastic muscle biopsy. Mod Pathol 1998;11:324-8. PMID 9578083
117: Romero NB. Centronuclear myopathies: a widening concept. Neuromusc Disord 2010;20:223-8. PMID 20181480
118: Rowinsky-Marcinska K, Strugalska MH, Hausmanowa-Petrusewicz I. Fiber density in congenital muscle fiber type disproportion. I. Congenital myopathies. Electromyogr Clin Neurophysiol 1990;30:475-81. PMID 2286172
119: Rowinsky-Marcinska K, Strugalska MH, Hausmanowa-Petrusewicz I. Fiber density in congenital muscle fiber type disproportion. II. Congenital muscle hypotonia and hip dislocation. Electromyogr Clin Neurophysiol 1991;31:5-8. PMID 2009826
120: Rudnik-Schöneborn S, Wallgren-Pettersson C. Pregnancy and delivery in women with congenital myopathies. Semin Pediatr Neurol 2019;29:23-9. PMID 31060722
121: Ruggiero L, Fiorillo C, Gibertini S, et al. A rare mutation in MYH7 gene occurs with overlapping phenotype. Biochem Biophys Res Commun 2015a;457(3):262-6. PMID 25576864
122: Ruggiero L, Fiorillo C, Tessa A, et al. Muscle fiber type disproportion (FTD) in a family with mutations in the LMNA gene. Muscle Nerve 2015b;51(4):604-8. PMID 25256213
123: Salmons S, Sreter FA. Significance of impulse activity in the transformation of skeletal muscle type. Nature 1976;263:30-4. PMID 958462
124: Sarnat HB. Muscle Pathology and Histochemistry. Chicago: Am Soc Clin Pathol Pr, 1983:51-3.
125: Sarnat HB. Le cerveau influence-t-il le développement musculaire du foetus humain. Mise en évidence de 21 cas. Can J Neurol Sci 1985;12:111-20. PMID 4016591
126: Sarnat HB. Cerebral dysgeneses and their influence on fetal muscle development. Brain Dev 1986;8:495-9. PMID 3541664
127: Sarnat HB. Do the corticospinal and corticobulbar tracts mediate functions the human newborn. Can J Neurol Sci 1989;16:157-60. PMID 2731081
128: Sarnat HB. Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle. Can J Neurol Sci 1990;17:109-23. PMID 2357647
129: Sarnat HB. Vimentin and desmin in maturing skeletal muscle and developmental myopathies. Neurology 1992;42:1616-24. PMID 1641160
130: Sarnat HB. New insights into the pathogenesis of congenital myopathies. J Child Neurol 1994;9:193-201. PMID 8006374
131: Sarnat HB. Ontogenesis of striated muscle. In: Polin RA, Fox WW, Abman SH, editors. Fetal and Neonatal Physiology. 5th ed. Philadelphia: Elsevier, 2016.
132: Sarnat HB, Alcala H. Human cerebellar hypoplasia. A syndrome of diverse causes. Arch Neurol 1980;37:300-5. PMID 7387451
133: Sarnat HB, Carpenter S. Muscle biopsy for diagnosis of neuromuscular and metabolic diseases. In: Darras BT, Royden Jones Jr, Ryan MM, De Vivo DC, editors. Neuromuscular disorders of infancy, childhood, and adolescence. a clinician’s approach. 2nd ed. Amsterdam, Boston: Elsevier, Academic Press, 2015:46-65.
134: Sarnat HB, Netsky MG. Hypothesis: phylogenetic diseases of the nervous system. Can J Neurol Sci 1984;11:29-33. PMID 6704791
135: Sarnat HB, Silbert SW. Maturational arrest of fetal muscle: neonatal myotonic dystrophy. A pathologic study of four cases. Arch Neurol 1976;33:466-74. PMID 132914
136: Schessl J, Goemans NM, Magold AI, et al. Predominant fiber atrophy and fiber type disproportion in early Ullrich disease. Muscle Nerve 2008;38:1184-91. PMID 18720506
137: Seay AR, Ziter FA, Petajan JH. Rigid spine syndrome: a type I fiber myopathy. Arch Neurol 1977;34:119-22. PMID 836180
138: Seigler RS, Golding EM Jr, Rogers C. A child with both congenital fiber type disproportion and giant congenital melanocytic nevi with malignant melanoma. J S C Med Assoc 1997;93(10):374-6. PMID 9343958
139: Sekulic-Jablanovic M, Palmowski-Wolfe A, Zorzato F, Treves S. Characterization of excitation-contraction coupling components in human extraocular muscles. Biochem J 2015;466(1):29-36. PMID 25387602
140: Selcen D. Severe congenital actin related myopathy with myofibrillar myopathy features. Neuromusc Disord 2015;25(6):488-92. PMID 25913210
141: Sewry CA, Wallgren-Pettersson C. Myopathology in congenital myopathies. Neuropathol Appl Neurobiol 2017;43(1):5-23. PMID 27976420
142: Sharma MC, Jain D, Sarkar C, Goebel HH. Congenital myopathies--a comprehensive update of recent advances. Acta Neurol Scand 2009;119:281-92. PMID 19133863
143: Sharma MC, Ralte AM, Atri SK, Gulati S, Kalra V, Sarkar C. Congenital fiber type disproportion: a rare type of congenital myopathy: a report of four cases. Neurol India 2004;52:254-6. PMID 15269486
144: Shibata R, Kusakawa I, Ozawa M, et al. A case of congenital myopathy with the pathologic transformation from fiber type disproportion to type 1 fiber predominance myopathy. No To Hattatsu 1998;30(4):307-11. PMID 9695625
145: Shimomura C, Nonaka I. Nemaline myopathy: comparative muscle histochemistry in the severe neonatal, moderate congenital and adult-onset forms. Pediatr Neurol 1989;5:25-31. PMID 2712935
146: Shishikura K, Osawa M, Suzuki H, et al. Clinical variability of congenital myopathy with type I fiber atrophy: a long-term observation of three cases. Acta Paediatr Jpn 1994;36(2):186-93. PMID 8203265
147: Simon R, Mateos F, Seijo M, Balseiro J, Madero S, Cabello A. [Congenital fiber-type disproportion: analysis of a series of 11 cases]. Neurologia 1991;6(8):281-6. PMID 1790004
148: Sobrido MJ, Fernandez JM, Fontoira E, et al. Autosomal dominant congenital fibre type disproportion: a clinicopathological and imaging study of a large family. Brain 2005;128:1716-27. PMID 15857933
149: Spiro AJ, Horoupian DS, Snyder DR. Biopsy and autopsy studies of congenital muscle fiber type disproportion: a broadening concept [abstract]. Neurology 1977;27:405.
150: Sulaiman A, Swick HM, Kinder DS. Congenital fibre type disproportion with unusual clinco-pathologic manifestations. J Neurol Neurosurg Psychiatry 1983;46:175-82. PMID 6842223
151: Szigeti K, Saifi GM, Armstrong D, Belmont JW, Miller G, Lupski JR. Disturbance of muscle fiber differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation. Ann Neurol 2003;54(3):398-402. PMID 12953275
152: Tachi N, Fujibayashi S, Wagatsuma K, Minami R, Imamura S. A case of multiple sulfatase deficiency with fiber type disproportion [abstract]. Brain Dev 1985;7:62. PMID 6466494
153: Tadokoro K, Ohta Y, Sasaki R, et al. Congenital myopathy with fiber-type disproportion accompanied by dilated cardiomyopathy in a patient with a novel p.G48A ACTA1 mutation. J Neurol Sci 2018;393:142-4. PMID 30195123
154: Tominaga K, Hayashi YK, Goto K, et al. Congenital myotonic dystrophy can show congenital fiber type disproportion pathology. Acta Neuropathol 2010;119:481-6. PMID 20179953
155: Torres CF, Moxley RT. Early predictors of poor outcome in congenital fiber-type disproportion myopathy. Arch Neurol 1992;49:855-6. PMID 1524518
156: Vallat JM, Lagueny A, Luchmaya K. Nonprogressive congenital neuromuscular disease with uniform type I fiber [letter]. Arch Neurol 1983;40:828-9. PMID 6639415
157: Vandamme D, Rommelaere H, Lambert E, et al. Alpha-skeletal muscle actin mutants causing different congenital myopathies induce similar cytoskeletal defects in cell line cultures. Cell Motil Cytoskeleton 2009;66(4):179-92. PMID 19206168
158: Vanek J, Janda J, Amblerova V, Losan F. Freeman-Sheldon syndrome: a disorder of congenital myopathic origin. J Med Genet 1986;23:231-6. PMID 3723551
159: Vasli N, Harris E, Karamchandani J, et al. Recessive mutations in the kinase ZAK cause a congenital myopathy with fibre-type disproportion. Brain 2017;140(1):37-48.
160: Vattemi G, Tonin P, Neri M, et al. Calpain 3 deficiency presenting as fiber type disproportion. Neuropathol Appl Neurobiol 2009;35:614-7. PMID 19490426
161: Vestergaard H, Klein HH, Hansen T, et al. Severe insulin-resistant diabetes mellitus in fiber type disproportion myopathy. J Clin Invest 1995;95:1925-32. PMID 7706500
162: Voit T, Krogmann D, Lenard HG, et al. Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis. Neuropediatrics 1988;19:62-71. PMID 3374765
163: Vorwerk P, Christoffersen CT, Muller J, et al. Alternative splicing of exon 17 and a missense mutation in the insulin receptor gene in two brothers with insulin resistance (congenital fiber-type disproportion) myopathy. Horm Res 1999;52:211-20. PMID 10844410
164: Waddell LB, Kreissl M, Kornberg A, et al. Evidence for a dominant negative disease mechanism in cap myopathy due to TPM3. Neuromusc Disord 2010;20(7):464-6. PMID 20554445
165: Willis T, Hedberg-Oldfors C, Alhaswaani Z, Kulshrestha R, Sewry C, Oldfors A. A novel MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness. J Neurol 2016;263(7):1427-33. PMID 27177998
166: Wilmshurst JM, Lillis D, Zhou H, et al. RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol 2010;68(5):717-26. PMID 20839240
167: Younger DS. Congenital myopathies. Handb Clin Neurol 2023;195:533-61. PMID 37562885
168: Zalneraitis EL, Grunnet ML, Russman BS. Ultrastructural evidence of myofiber atrophy distinguishes benign congenital fiber type disproportion from progressive denervating conditions [abstract]. J Neuropathol Exp Neurol 1989;48:373.
169: Zanoteli E, Oliveira AS, Kiyomoto BH, Schmidt B, Gabbai AA. Centronuclear myopathy. Histopathological aspects in ten patients with childhood onset. Arq Neuropsiquiatr 1998;56(1):1-8. PMID 9686113

Patient Profile

Age range of presentation: 0 month to 44 years
Sex preponderance: male=female
Heredity: heredity may be a factor

autosomal recessive
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Congenital muscle fiber-type disproportion

Associated Disorders

Trendelenburg gait
Krabbe globoid cell leukodystrophy
Pompe disease
Mitochondrial cytopathies
Moebius syndrome
- Myasthenia gravis, congenital
- Cori-Forbes disease
- Emery-Dreifuss X-linked muscular dystrophy
- Ullrich (collagen VI) muscular dystrophy
- Nemaline rod myopathy
- Cerebellar hypoplasia
- Multiple sulfatase deficiencies
- Debrancher enzyme deficiency
- Calpain 3 deficiency
- PHOX2B mutation

Differential Diagnosis

myotonic muscular dystrophy
nemaline rod myopathy
glycogenoses
Krabbe leukodystrophy
Lowe disease
- multiple sulfatase deficiency
- mitochondrial cytopathies
- rigid spine myopathy
- cerebellar hypoplasia
- fetal alcohol syndrome
- Werdnig-Hoffmann disease
- x-linked myotubular myopathy
- infantile myotonic dystrophy
- infantile spinal muscular atrophy

Congenital muscle fiber-type disproportion

Congenital muscle fiber-type disproportion

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Table 1. Differential Diagnosis of Congenital Muscle Fiber-Type Disproportion Syndrome

Epidemiology

Differential diagnosis

Diagnostic workup

Management

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Neurogenetics and genetic and genomic testing

Cerebro-oculo-facio-skeletal syndrome

Asymptomatic hyperCKemia

Limb-girdle muscular dystrophies

Chronic progressive external ophthalmoplegia

Schizencephaly

Fetal anticonvulsant syndrome

Congenital muscle fiber-type disproportion

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Table 1. Differential Diagnosis of Congenital Muscle Fiber-Type Disproportion Syndrome

Epidemiology

Differential diagnosis

Diagnostic workup

Management

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

X-linked hydrocephalus (L1 syndrome)

Neurogenetics and genetic and genomic testing

Cerebro-oculo-facio-skeletal syndrome

Asymptomatic hyperCKemia

Limb-girdle muscular dystrophies

Chronic progressive external ophthalmoplegia

Schizencephaly

Fetal anticonvulsant syndrome

This is an article preview.
Start a Free Account
to access the full version.